首页> 美国卫生研究院文献>The Scientific World Journal >Control of Cryptococcus Gattii Biofilms by an Ethanolic Extract of Cochlospermum Regium (Schrank) Pilger Leaves
【2h】

Control of Cryptococcus Gattii Biofilms by an Ethanolic Extract of Cochlospermum Regium (Schrank) Pilger Leaves

机译:香菇提取物的乙醇提取物控制隐球菌的生物膜。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cryptococcus gattii is an etiologic agent of cryptococcosis and a serious disease that affects immunocompromised and immunocompetent patients worldwide. The therapeutic arsenal used to treat cryptococcosis is limited to a few antifungal agents, and the ability of C. gattii to form biofilms may hinder treatment and decrease its susceptibility to antifungal agents. The objective of this study was to evaluate the antifungal and antibiofilm activities of an ethanolic extract of Cochlospermum regium (Schrank) Pilger leaves against C. gattii. The antifungal activity was assessed by measuring the minimum inhibitory concentration (MIC) using the broth microdilution technique and interaction of the extract with fluconazole was performed of checkerboard assay. The antibiofilm activity of the extract was evaluated in 96-well polystyrene microplates, and the biofilms were quantified by counting colony forming units. The extract showed antifungal activity at concentrations of 62.5 to 250 μg/mL and when the extract was evaluated in combination with fluconazole, C. gattii was inhibited at sub-MIC levels. The antibiofilm activity of the extract against C. gattii was observed both during biofilm formation and on an already established biofilm. The results showed that the ethanolic extract of the leaves of C. regium shows promise for the development of antifungal drugs to treat cryptococcosis and to combat C. gattii biofilms.
机译:加蒂隐球菌是隐球菌病的病原体,是一种严重的疾病,会影响全世界免疫功能低下和具有免疫能力的患者。用于治疗隐球菌病的治疗性阿森纳仅限于几种抗真菌药,加蒂梭菌形成生物膜的能力可能会阻碍治疗并降低其对抗真菌药的敏感性。这项研究的目的是评估Cochlospermum regium(Schrank)Pilger叶片的乙醇提取物对加迪梭菌的抗真菌和抗生物膜活性。通过使用肉汤微稀释技术测量最小抑菌浓度(MIC)评估抗真菌活性,并通过棋盘法进行提取物与氟康唑的相互作用。在96孔聚苯乙烯微孔板中评估提取物的抗生物膜活性,并通过计算菌落形成单位来定量生物膜。提取物在62.5至250μg/ mL的浓度下显示出抗真菌活性,当将提取物与氟康唑联合评估时,加蒂梭菌在亚MIC水平下受到抑制。在生物膜形成过程中和已经建立的生物膜上均观察到提取物对加迪梭菌的抗生物膜活性。结果表明,C。regium叶片的乙醇提取物显示出有望开发出抗真菌药,以治疗隐球菌病和对抗C. gattii生物膜。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号